|
End-of-day quote
Nasdaq
2026-10-01
|
5-day change | 1st Jan Change | ||
| 0.7441 USD | -4.88% |
|
-27.76% | -99.05% |
| 09-24 | SRX Global Inc. acquired an unknown minority stake in Onconetix, Inc.. | CI |
| 09-24 | SRX Global Makes Investment in Onconetix | MT |
Company Valuation: Onconetix, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Market Cap 1 | 17.02 | 3.635 | 5.224 | 2.426 |
| Change | - | -78.64% | 43.7% | -53.56% |
| Enterprise Value (EV) 1 | -8.736 | 8.967 | 14.02 | -2.746 |
| Change | - | 202.64% | 56.41% | -119.58% |
| P/E | - | - | - | -0.09x |
| PBR | - | - | - | 0.15x |
| PEG | - | - | - | - |
| Capitalization / Revenue | - | 62,178,226x | 2,069,558x | 2,975,087x |
| EV / Revenue | - | - | - | - |
| EV / EBITDA | 0.66x | -0.57x | -1.9x | 0.43x |
| EV / EBIT | 0.66x | -0.56x | -1.72x | 0.43x |
| EV / FCF | 2.61x | -0.56x | -10.4x | 0.61x |
| FCF Yield | 38.3% | -179% | -9.64% | 164% |
| Dividend per Share 2 | - | - | - | - |
| Rate of return | - | - | - | - |
| EPS 2 | - | - | - | -828.1 |
| Distribution rate | - | - | - | - |
| Net sales | - | 0.0585 | 2.524 | 0.8154 |
| EBITDA 1 | -13.17 | -15.84 | -7.4 | -6.33 |
| EBIT 1 | -13.18 | -15.88 | -8.131 | -6.345 |
| Net income 1 | -13.42 | -37.41 | -58.69 | -14.03 |
| Net Debt 1 | -25.75 | 5.331 | 8.801 | -5.172 |
| Reference price 2 | 186,998.5040 | 33,659.7307 | 2,677.5013 | 78.0000 |
| Nbr of stocks (in thousands) | 0.09 | 0.11 | 1.95 | 31.1 |
| Announcement Date | 3/9/23 | 4/11/24 | 6/2/25 | 3/13/26 |
1USD in Million2USD
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 2.9M | |
| 32.45x | 11.78x | 23.93x | 0.61% | 1,019B | |
| 28.48x | 6.32x | 17.7x | 2.09% | 617B | |
| 33.26x | 7.78x | 16.08x | 2.64% | 464B | |
| 104.98x | 5.87x | 24.89x | 2.36% | 356B | |
| 18.81x | 4.58x | 11.36x | 2.9% | 333B | |
| 19.83x | 5.17x | 12.78x | 3.09% | 267B | |
| 20.02x | 4.17x | 11.86x | 2.13% | 244B | |
| 25.46x | 6.66x | 11.86x | 2.5% | 218B | |
| -43.78x | 6.39x | 24.97x | 2.27% | 179B | |
| Average | 26.61x | 6.52x | 17.27x | 2.29% | 369.72B | |
| Weighted average by Cap. | 31.80x | 7.61x | 18.61x | 1.96% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ONCO Stock
- Valuation Onconetix, Inc.
Select your edition
All financial news and data tailored to specific country editions
